Michael Dickinson
@mike_dickinson1
Haem/onc @Haem_pmcc_rmh in Melbourne. #Lymphoma Lead #CART Early phase trials. Lymphoma co-Chair @ALLGtrials Views are my own. #lymsm
ID:27204938
https://www.petermac.org/users/dr-michael-dickinson 28-03-2009 09:42:13
1,1K Tweets
2,0K Followers
1,3K Following
Great to see our consensus guidelines on CD20x3 #bispecific safety management in a nice PDF @bloodjournal bit.ly/3SvFfhl. Hopefully a useful resource for the roll out of these potent drugs #lymsm #glofitamab #Epcoritamab #mosunetuzumab
T-cell lymphoma: the CAR-T revolution is coming
ow.ly/CWb550R4wnN #clinicaltrialsandobservations
I am gratified to have participated on behalf of Peter Mac Cancer Centre in this exceptional work by a global team, led by the incredibly energetic and affable Michael Sargent Binkley and Jamie Flerlage
Pleased to say that I have recently been promoted to Professor University of Melbourne. I look forward to many more years of contributing to lymphoma research and to improving outcomes for patients with lymphoma. @petermaccc Lymphoma Australia #Lymsm
Just out in Journal of Clinical Oncology the VALDAC study of LDAC+Ven for MRD relapse or oligoblastic relapse in AML
MRD group: 46% MRD negativity
oligoblastic group: 73% CR/CRh/CRi
2 year OS 67% in MRD group, 53% in oligoblastic group
ascopubs.org/doi/10.1200/JC… Haematology Peter MacCallum CC & Royal Melbourne Peter Mac Research #leusm
So incredibly proud of Dineika Chandra who is so deserving of this recognition. A great leader within The Dawson Lab
Delighted to share the results of our MARTA trial, just published in The Lancet Haematology. A collaborative effort of the German PCNSL Study Group. We are deeply thankful for the support of all collaborators and Else Kröner-Fresenius-Stiftung
authors.elsevier.com/a/1iW3b_rV3GEO…
So pleased to work with Jennifer Crombie, MD @falchi_Lorenzo and a great team of authors from around the world and from a variety of treatment settings on these recommendations for #bispecifics . Now available @bloodjournal #lymsm Lymphoma Research Foundation Lymphoma Research Foundationoz bit.ly/3SvFfhl
Helpful to see these methods for high quality RWD from the LYSA in Blood Advances Quality is a challenge in RW data sets. If lacking, effort wasted. Three levels of QC. Focus on clinical consistency checks and automation of queries. Lots of time and care. #lymsm Lymphoma Australia
A great team effort: LBCL is getting complicated!
R/R guideline to follow....
doi.org/10.1111/bjh.19…
Andrew Davies Sridhar Chaganti Pam McKay Toby Eyre Sally Barrington Andrea Kuhnl Kate Cwynarski #GMcIlroy #CBurton #TIllidge @NKalakonda LymphomaAction BSH - Haematology
New Review: Epstein–Barr virus-associated lymphomas decoded onlinelibrary.wiley.com/doi/10.1111/bj… #lymsm #EBV #lymphoma
The Fraser Institute UQ Medicine Translational Research Institute PA Hospital Brisbane @QIMRBerghofer Mater Research
